JPS6241706B2 - - Google Patents
Info
- Publication number
- JPS6241706B2 JPS6241706B2 JP14728883A JP14728883A JPS6241706B2 JP S6241706 B2 JPS6241706 B2 JP S6241706B2 JP 14728883 A JP14728883 A JP 14728883A JP 14728883 A JP14728883 A JP 14728883A JP S6241706 B2 JPS6241706 B2 JP S6241706B2
- Authority
- JP
- Japan
- Prior art keywords
- carbobenzyloxy
- glutamic acid
- acid
- producing
- choline ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960001231 choline Drugs 0.000 claims description 23
- 238000004519 manufacturing process Methods 0.000 claims description 8
- PVFCXMDXBIEMQG-JTQLQIEISA-N (2s)-2-(phenylmethoxycarbonylamino)pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 PVFCXMDXBIEMQG-JTQLQIEISA-N 0.000 claims description 5
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 4
- 238000010306 acid treatment Methods 0.000 claims description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- -1 methyl halide Chemical class 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 239000002841 Lewis acid Substances 0.000 claims 1
- 235000011054 acetic acid Nutrition 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims 1
- 150000007517 lewis acids Chemical class 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 1
- 229960002989 glutamic acid Drugs 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000007858 starting material Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 238000011109 contamination Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WQMAANNAZKNUDL-UHFFFAOYSA-N 2-dimethylaminoethyl chloride Chemical compound CN(C)CCCl WQMAANNAZKNUDL-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Description
〔産業上の利用分野〕
本発明は、Ｎ−カルボベンジルオキシ−Ｌ−グ
ルタミン酸−γ−コリンエステル塩の製造法、特
にその異性体のＮ−カルボベンジルオキシ−Ｌ−
グルタミン酸−α−コリンエステル塩（以下「α
−体」という）の混在しないＮ−カルボベンジル
オキシ−Ｌ−グルタミン酸−γ−コリンエステル
塩の製造法に関する。
〔技術の背景および従来技術の説明〕
Ｎ−カルボベンジルオキシ−Ｌ−グルタミン酸
−γ−コリンエステル塩化物は、血圧降下剤、抗
脂肝剤および小児麻痺治療剤として有用であるこ
とが知られている。〔日化：第72巻、第３号、第
46〜47頁（昭和26年３月）、ビタミン：第７巻、
第４号、別冊、第428〜467頁（昭和29年４月）
他〕この公知方法によると、Ｎ−カルボベンジル
オキシ−Ｌ−グルタミン酸−γ−コリンエステル
塩は、その異性体のα−体とともに併産混合物の
形で得られる。しかしながら、Ｎ−カルボベンジ
ルオキシ−Ｌ−グルタミン酸−γ−コリンエステ
ル塩とその異性体のα−体は以下に示す化学構造
を有していて、その理化学的性質が極めて近似し
ているために、両者を単離し、精製することが非
常に難かしい。
本発明者らは、Ｎ−カルボベンジルオキシ−Ｌ
−グルタミン酸−γ−コリンエステル塩を、その
異性体のα−体を含まない状態で製造しうる方法
について研究を重ね、その合成における出発物質
のＮ−カルボベンジルオキシ−α−第３級ブチル
−Ｌ−グルタミン酸ジシクロヘキシルアンモニウ
ム塩が、その近縁化合物のＮ−カルボベンジルオ
キシ−α−第３級ブチル−Ｌ−グルタミン酸など
に比べて、結晶化しやすく、また溶媒による精製
も容易で、高純度のものが得られやすいことを見
出し、この知見にもとずいて本発明に到達したの
である。
〔発明の目的および発明の要約〕
本発明の目的は、本発明の目的化合物の異性体
であるＮ−カルボベンジルオキシ−Ｌ−グルタミ
ン酸−α−コリンエステル塩（α−体）の混在し
ないＮ−カルボベンジルオキシ−Ｌ−グルタミン
酸−γ−コリンエステル塩を工業的に製造するこ
とができる方法を提供することにある。
本発明は、
ａ Ｎ−カルボベンジルオキシ−α−第３級ブチ
ル−Ｌ−グルタミン酸ジシクロヘキシルアンモ
ニウム塩を出発物質とし、これにジメチルアミ
ノエチルクロライドを反応させて、Ｎ−カルボ
ベンジルオキシ−α−第３級ブチル−Ｌ−グル
タミン酸−γ−ジメチルアミノエチルエステル
をつくる第１段階の反応、
ｂ ここに得られたＮ−カルボベンジルオキシ−
α−第３級ブチル−Ｌ−グルタミン酸−γ−ジ
メチルアミノエチルエステルに、ジメチルアミ
ノ基の第４級化剤を反応させて、前者のジメチ
ルアミノ基を第４級化し、これによつてＮ−カ
ルボベンジルオキシ−α−第３級ブチル−Ｌ−
グルタミン酸−γ−コリンエステル塩をつくる
ことからなる第２段階の反応、および
ｃ ここに得られたＮ−カルボベンジルオキシ−
α−第３級ブチル−Ｌ−グルタミン酸−γ−コ
リンエステル塩に穏和な酸処理を行なつて、α
−位置の第３級ブチル基を選択的に離脱させ、
これによつてＮ−カルボベンジルオキシ−Ｌ−
グルタミン酸−γ−コリンエステルをつくるこ
とからなる第３段階の反応、の各反応からなる
Ｎ−カルボベンジルオキシ−Ｌ−グルタミン酸
−γ−コリンエステル塩の製造法である。
〔発明の具体的な説明〕
本発明によると、その目的化合物のＮ−カルボ
ベンジルオキシ−Ｌ−グルタミン酸−γ−コリン
エステル塩は、Ｎ−カルボベンジルオキシ−α−
第３級ブチル−Ｌ−グルタミン酸ジシクロヘキシ
ルアンモニウム塩を出発物質とする上記の各段階
の反応を行なうことによつてつくられる。
本発明の上記の各段階の反応を化学式によつて
示すと、次のとおりである。
[Industrial Application Field] The present invention relates to a method for producing N-carbobenzyloxy-L-glutamic acid γ-choline ester salt, particularly its isomer N-carbobenzyloxy-L-
Glutamic acid α-choline ester salt (hereinafter referred to as “α
The present invention relates to a method for producing N-carbobenzyloxy-L-glutamic acid γ-choline ester salt without contamination. [Technical Background and Description of the Prior Art] N-carbobenzyloxy-L-glutamic acid-γ-choline ester chloride is known to be useful as an antihypertensive agent, an anti-fatty liver agent, and a therapeutic agent for infantile paralysis. There is. [Nikka: Volume 72, No. 3, No.
pp. 46-47 (March 1952), Vitamins: Volume 7,
No. 4, separate issue, pages 428-467 (April 1952)
According to this known method, N-carbobenzyloxy-L-glutamic acid-γ-choline ester salt is obtained in the form of a co-product mixture together with its isomer α-isomer. However, N-carbobenzyloxy-L-glutamic acid γ-choline ester salt and its isomer α-form have the chemical structures shown below, and their physicochemical properties are very similar, so Both are extremely difficult to isolate and purify. The inventors have discovered that N-carbobenzyloxy-L
- Research has been carried out on a method for producing glutamic acid γ-choline ester salt without its α-isomer, and the starting material for its synthesis is N-carbobenzyloxy-α-tertiary butyl- L-glutamic acid dicyclohexylammonium salt crystallizes more easily than its closely related compound, N-carbobenzyloxy-α-tertiary butyl-L-glutamic acid, and is also easy to purify with a solvent, making it highly pure. They found that it was easy to obtain, and based on this knowledge, they arrived at the present invention. [Object of the Invention and Summary of the Invention] The object of the present invention is to obtain N-carbobenzyloxy-L-glutamic acid-α-choline ester salt (α-isomer), which is an isomer of the target compound of the present invention, without contamination. An object of the present invention is to provide a method for industrially producing carbobenzyloxy-L-glutamic acid γ-choline ester salt. The present invention uses a N-carbobenzyloxy-α-tertiary butyl-L-glutamic acid dicyclohexylammonium salt as a starting material, and reacts this with dimethylaminoethyl chloride to form N-carbobenzyloxy-α-tertiary butyl First step reaction to produce butyl-L-glutamic acid γ-dimethylaminoethyl ester, b. N-carbobenzyloxy-
α-Tertiary butyl-L-glutamic acid-γ-dimethylaminoethyl ester is reacted with a dimethylamino group quaternizing agent to quaternize the dimethylamino group of the former, thereby producing N- Carbobenzyloxy-α-tertiary butyl-L-
The second step reaction consists of making the glutamic acid-γ-choline ester salt, and c the N-carbobenzyloxy-
α-Tertiary butyl-L-glutamic acid-γ-choline ester salt is subjected to mild acid treatment,
selectively removing the tertiary butyl group at the - position,
This gives N-carbobenzyloxy-L-
This is a method for producing N-carbobenzyloxy-L-glutamic acid-gamma-choline ester salt, which comprises the following reactions: the third step reaction consists of producing glutamic acid-gamma-choline ester. [Detailed Description of the Invention] According to the present invention, the target compound N-carbobenzyloxy-L-glutamic acid-γ-choline ester salt is N-carbobenzyloxy-α-
It is produced by carrying out the reactions in each of the above steps using tertiary butyl-L-glutamic acid dicyclohexylammonium salt as a starting material. The reactions in each of the above steps of the present invention are shown by chemical formulas as follows.
出発物質として、精製の容易なＮ−カルボベン
ジルオキシ−α−第３級ブチル−Ｌ−グルタミン
酸ジシクロヘキシルアンモニウム塩を使用するこ
とによつて、Ｎ−カルボベンジルオキシ−Ｌ−グ
ルタミン酸−α−コリンエステル塩（α−体）の
混在しないＮ−カルボベンジルオキシ−Ｌ−グル
タミン酸−γ−コリンエステル塩（γ−体）を得
ることができる。
By using easily purified N-carbobenzyloxy-α-tertiary butyl-L-glutamic acid dicyclohexylammonium salt as a starting material, N-carbobenzyloxy-L-glutamic acid-α-choline ester salt was prepared. It is possible to obtain N-carbobenzyloxy-L-glutamic acid-γ-choline ester salt (γ-form) that does not contain (α-form).
Claims (1)
ブチル−Ｌ−グルタミン酸ジシクロヘキシルア
ンモニウム塩とジメチルアミノエチルクロライ
ドを反応させて、Ｎ−カルボベンジルオキシ−
α−第３級ブチル−Ｌ−グルタミン酸−γ−ジ
メチルアミノエチルエステルをつくること、 ｂ Ｎ−カルボベンジルオキシ−α−第３級ブチ
ル−Ｌ−グルタミン酸−γ−ジメチルアミノエ
チルエステルに、ジメチルアミノ基の第４級化
剤を反応させて、前者のジメチルアミノ基を第
４級化し、これによつて、Ｎ−カルボベンジル
オキシ−α−第３級ブチル−Ｌ−グルタミン酸
−γ−コリンエステル塩をつくること、および ｃ Ｎ−カルボベンジルオキシ−α−第３級ブチ
ル−Ｌ−グルタミン酸−γ−コリンエステル塩
に穏和な酸処理を行なつて、α−位置の第３級
ブチル基を選択的に離脱させ、これによつて、
Ｎ−カルボベンジルオキシ−Ｌ−グルタミン酸
−γ−コリンエステル塩をつくること、 を特徴とするＮ−カルボベンジルオキシ−Ｌ−グ
ルタミン酸−γ−コリンエステル塩の製造法。 ２ ジメチルアミノ基の第４級化剤が、ハロゲン
化メチルであることを特徴とする特許請求の範囲
第１項に記載のＮ−カルボベンジルオキシ−Ｌ−
グルタミン酸−γ−コリンエステルハロゲン塩の
製造法。 ３ ジメチルアミノ基の第４級化剤が、有機スル
ホン酸メチルであることを特徴とする特許請求の
範囲第１項に記載のＮ−カルボベンジルオキシ−
Ｌ−グルタミン酸−γ−コリンエステル塩の製造
法。 ４ 穏和な酸処理が、トリフロロ酢酸、塩化水
素、酢酸、ギ酸、プロピオン酸、パラトルエンス
ルホン酸およびルイス酸からなる群より選択され
た酸によつて行なわれることを特徴とする特許請
求の範囲第１項ないし第３項のいずれかに記載の
Ｎ−カルボベンジルオキシ−Ｌ−グルタミン酸−
γ−コリンエステル塩の製造法。[Scope of Claims] 1 a N-carbobenzyloxy-
producing α-tert-butyl-L-glutamic acid-γ-dimethylaminoethyl ester, b. to quaternize the dimethylamino group of the former, thereby producing N-carbobenzyloxy-α-tert-butyl-L-glutamic acid-γ-choline ester salt. and c N-carbobenzyloxy-α-tert-butyl-L-glutamic acid-γ-choline ester salt is subjected to mild acid treatment to selectively remove the tertiary butyl group at the α-position. to separate, thereby
1. A method for producing N-carbobenzyloxy-L-glutamic acid-γ-choline ester salt, which comprises producing N-carbobenzyloxy-L-glutamic acid-γ-choline ester salt. 2. N-carbobenzyloxy-L- according to claim 1, wherein the dimethylamino group quaternizing agent is methyl halide.
Method for producing glutamic acid-γ-choline ester halogen salt. 3. The N-carbobenzyloxy-
Method for producing L-glutamic acid-γ-choline ester salt. 4. The mild acid treatment is carried out with an acid selected from the group consisting of trifluoroacetic acid, hydrogen chloride, acetic acid, formic acid, propionic acid, para-toluenesulfonic acid and Lewis acid. N-carbobenzyloxy-L-glutamic acid according to any one of items 1 to 3.
Method for producing γ-choline ester salt.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14728883A JPS6041652A (en) | 1983-08-13 | 1983-08-13 | Preparation of n-carbobenzyloxy-l-glutamic acid-gamma- choline ester salt |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14728883A JPS6041652A (en) | 1983-08-13 | 1983-08-13 | Preparation of n-carbobenzyloxy-l-glutamic acid-gamma- choline ester salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6041652A JPS6041652A (en) | 1985-03-05 |
| JPS6241706B2 true JPS6241706B2 (en) | 1987-09-04 |
Family
ID=15426809
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14728883A Granted JPS6041652A (en) | 1983-08-13 | 1983-08-13 | Preparation of n-carbobenzyloxy-l-glutamic acid-gamma- choline ester salt |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6041652A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7807847B2 (en) * | 2004-07-09 | 2010-10-05 | Vascular Biogenics Ltd. | Process for the preparation of oxidized phospholipids |
-
1983
- 1983-08-13 JP JP14728883A patent/JPS6041652A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6041652A (en) | 1985-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1462447A3 (en) | Method for the preparation of pure citalopram | |
| JPH09216885A (en) | Improved production of n-(3-(3-cyanopyrozolo-(1,5-a)pyrimidin-7-yl)phenyl)-n-ethyl-acetamide | |
| JP2007536209A (en) | 1-Benzyl-4-[(5,6-dimethoxy-1-indanone) -2-yl] methylpiperidine oxalate (donepezyl oxalate) and polymorphs thereof | |
| JPH09110871A (en) | Preparation of imidazobenzodiazepine derivative | |
| JP3450389B2 (en) | Method for producing L-5- (2-acetoxy-propionylamino) -2,4,6-triiodo-isophthalic dichloride | |
| Hwu et al. | Silicon-promoted Nef reaction by a. gamma.-effect | |
| JP3677790B2 (en) | Nucleoside derivatives and process for producing the same | |
| JPS6241706B2 (en) | ||
| JPS6241707B2 (en) | ||
| JP2778103B2 (en) | Method for producing optically active threodihydroxyphenylserine derivative | |
| JP2020189856A5 (en) | ||
| EP3474847B1 (en) | Processes for the preparation of eluxadoline | |
| JPS606958B2 (en) | Antibiotic purification method | |
| JPH02215790A (en) | Recovery of hexamethyl disiloxane | |
| JPH07107033B2 (en) | Optically active 3-amino-4-cyclohexyl-2-hydroxybutyric acid hydrochloride and method for producing the same | |
| JP2003501425A5 (en) | ||
| EP0729941B1 (en) | Process for producing keto nitrile derivative and hexenone derivative | |
| JPH078853B2 (en) | Method for producing dopamine derivative | |
| JP2565034B2 (en) | Novel dopa derivative and its production method | |
| JPH101463A (en) | Production of n-lauroyl-l-glutamic acid-di-n-butylamide | |
| JPH0285235A (en) | Production of optically active amino-alcohols | |
| JPS6259295A (en) | Novel process for producing peptide | |
| JP3013760B2 (en) | Method for producing 4-hydroxy-2-pyrrolidone | |
| JPH0215065A (en) | Production of high-purity o-5,6,7,8-tetrahydronaphthyl-n-methyl-n-(6-methoxy-2-pyridyl)thiocarbamate | |
| JPH07103115B2 (en) | Method for crystallizing 2- (10,11-dihydro-10-oxodibenzo [b, f] thiepin-2-yl) propionic acid |